DUCHENNE MUSCULAR DYSTROPHY CARDIOMYOPATHY

Clinical trials for DUCHENNE MUSCULAR DYSTROPHY CARDIOMYOPATHY explained in plain language.

Never miss a new study

Get alerted when new DUCHENNE MUSCULAR DYSTROPHY CARDIOMYOPATHY trials appear

Sign up with your email to follow new studies for DUCHENNE MUSCULAR DYSTROPHY CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for duchenne hearts: experimental drug targets leading cause of death

Disease control Completed

This study tested ifetroban, an oral medication, to see if it could help control heart damage in boys and young men with Duchenne muscular dystrophy (DMD). Heart problems are now the leading cause of death for people with DMD. Forty-six participants took either the drug or a plac…

Matched conditions: DUCHENNE MUSCULAR DYSTROPHY CARDIOMYOPATHY

Phase: PHASE2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

DUCHENNE MUSCULAR DYSTROPHY CARDIOMYOPATHY

Get alerted when new DUCHENNE MUSCULAR DYSTROPHY CARDIOMYOPATHY trials appear

New hope for duchenne hearts: experimental drug targets leading cause of death